文献速递慢性静脉疾病

氰基丙烯酸酯闭合术治疗下肢浅静脉的超敏反应回顾性研究

Retrospective study of hypersensitivity reactions in patients undergoing cyanoacrylate closure of lower extremity superficial veins.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2025-04-09

该研究在麻省总医院百翰医疗系统纳入2018至2022年122例患者193条静脉,评估氰基丙烯酸酯闭合术后超敏反应的发生率、起病、持续时间、严重程度及危险因素。超敏反应发生率为21.2%,症状平均术后7.6天出现,多数为轻度(76%)或中度(24%)且自行缓解或经药物缓解;年轻、女性、过敏史、较长静脉及大隐静脉与超敏反应风险较高相关。术后总体闭合率为99.5%,有无超敏反应患者间无显著差异。

要点

  • 氰基丙烯酸酯闭合术后超敏反应发生率为21.2%,症状平均术后7.6天出现。
  • 超敏反应多数为轻度(76%)或中度(24%),可自行缓解或经非甾体抗炎药、类固醇治疗缓解。
  • 年轻、女性、过敏史、较长静脉及大隐静脉与超敏反应风险较高相关。

核心结论

  • 超敏反应是氰基丙烯酸酯闭合术的潜在不良并发症,多数病例呈自限性,影响较年轻、女性及有过敏史的患者。
  • 作者认为这些发现提示在考虑采用氰基丙烯酸酯闭合术治疗慢性静脉功能不全时需仔细选择患者并进行咨询。

研究设计与样本

  • 回顾性研究,在麻省总医院百翰医疗系统纳入2018至2022年122例患者共193条静脉。
  • 纳入标准为18岁及以上、有症状的下肢浅静脉功能不全,包括大隐静脉、小隐静脉及前副大隐静脉。
  • 收集患者人口学、临床病史、手术细节及术后双功超声结果。

主要发现

  • 超敏反应发生率为21.2%。
  • 症状平均在术后7.6天出现(标准差7.4天)。
  • 多数患者为轻度(76%)或中度(24%)症状,可自行缓解、经非甾体抗炎药或类固醇治疗缓解。
  • 超敏反应风险较高与年轻(P = .0372)、女性(P = .0025)及过敏史(P = .0049)显著相关。
  • 较长静脉(P = .0205)及大隐静脉(P = .0388)与超敏反应关联较强。

关键数值与推荐

  • 超敏反应发生率21.2%。
  • 症状出现时间平均7.6天(标准差7.4天)。
  • 严重程度:轻度76%,中度24%。
  • 风险因素P值:年轻P = .0372,女性P = .0025,过敏史P = .0049,较长静脉P = .0205,大隐静脉P = .0388。
  • 术后总体闭合率99.5%。

临床怎么用

  • 作者认为在考虑采用氰基丙烯酸酯闭合术治疗慢性静脉功能不全时需仔细选择患者并进行咨询。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Chronic venous insufficiency affects more than 25 million adults in the United States, who initially presents with varicose veins. Although thermal-based, minimally invasive endovenous procedures exist, there has been a recent advent of non-thermal endovenous methods for vein ablation such as cyanoacrylate closure (CAC) with the VenaSeal Closure System, which decreases the risk of thermal injury. This study aimed to determine the incidence, onset, duration, and severity of hypersensitivity reactions (HSRs) following CAC, as well as identify risk factors for the development of HSRs. METHODS: This study was conducted at the Massachusetts General Brigham health care system and included 122 patients with 193 veins treated between 2018 and 2022. Patients aged 18 years and older with symptomatic, incompetent superficial lower extremity veins, including the great saphenous vein, small saphenous vein, and anterior accessory saphenous vein, were included. Data on patient demographics, clinical history, procedure details, and post-procedural duplex ultrasound results were collected. RESULTS: In this cohort, the incidence of HSRs was 21.2%. Symptom onset occurred on average 7.6 days post-procedure (standard deviation, 7.4 days) with most patients experiencing mild (76%) or moderate (24%) symptoms that resolved without intervention, with non-steroidal anti-inflammatory drugs, or with steroid treatment. There was a significantly higher risk of HSRs with younger age (P = .0372), female sex (P = .0025), and history of allergies (P = .0049). Longer veins (P = .0205) and greater saphenous veins (P = .0388) had stronger associations with HSRs. The overall postoperative closure rate after CAC procedure was 99.5%, without a significant difference between patients with and without HSRs. CONCLUSIONS: HSRs are a potential adverse complication of the CAC procedure, with most cases being self-limited and affecting individuals who are younger, are female, and have a history of allergies. These findings suggest the need for careful patient selection and counseling during consideration of the CAC procedure for the treatment of chronic venous insufficiency.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Lee J, Png CYM, Mulaney-Topkar B, et al. Retrospective study of hypersensitivity reactions in patients undergoing cyanoacrylate closure of lower extremity superficial veins. J Vasc Surg Venous Lymphat Disord. 2025. PMID: 40204190. doi:10.1016/j.jvsv.2025.102246

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。